425: ChampionX to Divest US Synthetic Corporation to LongRange Capital for $300 Million

ChampionX Corporation has entered into an agreement to sell its US Synthetic Corporation to LongRange Capital for approximately $300 million in cash, contingent on customary closing conditions and the completion of ChampionX's merger with SLB.

Summary

• ChampionX Corporation has agreed to sell its US Synthetic Corporation to LongRange Capital for approximately $300 million.
• The sale is part of ChampionX's strategy in connection with its pending acquisition by SLB (Schlumberger).
• The purchase agreement includes customary representations, warranties, and covenants.
• Closing is subject to typical conditions, including regulatory approvals and the completion of the ChampionX-SLB merger.
• The agreement may be terminated under certain circumstances, including failure to close by April 2, 2025, or termination of the SLB merger agreement, with potential termination fees payable by ChampionX under specific conditions.
• The transaction is expected to close shortly after the closing of the ChampionX and SLB transaction.

Sentiment

Score: 7

Explanation: The sentiment is cautiously optimistic. The deal is positive for ChampionX as it streamlines operations, but there are risks related to closing conditions and the SLB merger. The management comments are positive, but the forward-looking statements acknowledge potential risks.

Positives

• The sale allows ChampionX to streamline its operations in connection with its pending acquisition by SLB.
• The transaction provides ChampionX with $300 million in cash, subject to adjustments.
• LongRange Capital's investment may foster further growth for US Synthetic.

Negatives

• ChampionX may be required to pay termination fees to Purchaser under specified circumstances if the deal does not close.
• The sale is contingent on the closing of the ChampionX and SLB transaction, introducing uncertainty.

Risks

• The transaction is subject to customary closing conditions, including regulatory approvals, which may not be obtained.
• The closing is contingent on the completion of the ChampionX and SLB transaction, which may face its own set of risks and uncertainties.
• Termination of the agreement could result in ChampionX owing fees to LongRange Capital.
• Forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The transaction is expected to close shortly after the closing of the previously announced transaction between ChampionX and SLB, subject to customary closing conditions.

Management Comments

• Sivasankaran Soma Somasundaram, President and CEO of ChampionX, expressed pleasure in US Synthetic's growth and thanked its employees.
• Rob Galloway, President, Drilling Technologies of ChampionX, is optimistic about the opportunities the transition will bring with LongRange Capital.

Industry Context

This divestiture is part of a larger trend of consolidation and strategic realignment within the oilfield services industry, as companies like ChampionX focus on core competencies and synergies following major acquisitions.

Comparison to Industry Standards

• The $300 million valuation is within the typical range for divestitures of specialized oilfield technology businesses, based on comparable transactions involving companies like National Oilwell Varco (NOV) and Baker Hughes.
• LongRange Capital's investment strategy aligns with other private equity firms focusing on operational improvements and growth in industrial sectors, similar to approaches taken by firms like KKR and Carlyle Group in past acquisitions.

Stakeholder Impact

• Shareholders: Positive impact due to increased cash and strategic focus.
• Employees of US Synthetic: Potential for growth under new ownership.
• Customers: Continued commitment to delivering exceptional value.
• Suppliers: No immediate impact expected.

Next Steps

• Obtain regulatory approvals.
• Satisfy customary closing conditions.
• Close the ChampionX and SLB transaction.
• Complete the sale of US Synthetic to LongRange Capital.

Key Dates